Thyroid cancer is the most prevalent endocrine tumor and its incidence is fast-growing
worldwide in recent years. Differentiated thyroid cancer (DTC) is the most common …

Context: Thyroid incidentaloma diagnosed by 2-[18F]-fluoro-2-deoxy-d-glucose positron
emission tomography/computed tomography (F-18-FDG-PET/CT) is defined as a thyroid …

Purpose This study investigated the utility of BRAF mutation testing of thyroid fine-needle
aspiration biopsy (FNAB) specimens for preoperative risk stratification in papillary thyroid …

Purpose: A multicenter, open-label, phase II trial was conducted to evaluate the efficacy,
safety, and tolerability of selumetinib in iodine-refractory papillary thyroid cancer (IRPTC) …

There is now a reasonably good understanding of the key oncogenic events involved in the
initiation and progression of thyroid cancer. Many of these are characteristic of certain tumor …

Papillary thyroid cancer (PTC) is the most common endocrine malignancy, accounting for 85–
90% of all thyroid cancers. Genetic alternations involving the mitogen-activated protein …

The standard treatment of differentiated thyroid cancer (DTC) consists of surgery followed by
iodine-131 (131 I) administration. Although the majority of DTC has a very good prognosis …

Background: The primary goals of this interdisciplinary consensus statement are to define
the eligibility criteria for management of recurrent and persistent cervical nodal disease in …

Staging and risk stratification predicate the postoperative management of thyroid cancer
patients, determining not only the need for 131I therapy or alternative options (conservative …

Differentiated thyroid cancer (DTC) is the most common endocrinological malignancy. There
are several histological variants such as papillary and follicular thyroid carcinoma. Many …